BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 27866040)

  • 1. In vitro fermentation of different fructo-oligosaccharides by Bifidobacterium strains for the selection of synbiotic combinations.
    Valdés-Varela L; Ruas-Madiedo P; Gueimonde M
    Int J Food Microbiol; 2017 Feb; 242():19-23. PubMed ID: 27866040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xylo-oligosaccharides and lactitol promote the growth of Bifidobacterium lactis and Lactobacillus species in pure cultures.
    Mäkeläinen H; Saarinen M; Stowell J; Rautonen N; Ouwehand AC
    Benef Microbes; 2010 Jun; 1(2):139-48. PubMed ID: 21840802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in vitro study of the effect of probiotics, prebiotics and synbiotics on the elderly faecal microbiota.
    Likotrafiti E; Tuohy KM; Gibson GR; Rastall RA
    Anaerobe; 2014 Jun; 27():50-5. PubMed ID: 24685554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Bifidobacterium upon Clostridium difficile Growth and Toxicity When Co-cultured in Different Prebiotic Substrates.
    Valdés-Varela L; Hernández-Barranco AM; Ruas-Madiedo P; Gueimonde M
    Front Microbiol; 2016; 7():738. PubMed ID: 27242753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An
    Kok CR; Gomez Quintero DF; Niyirora C; Rose D; Li A; Hutkins R
    Appl Environ Microbiol; 2019 Aug; 85(16):. PubMed ID: 31201276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exopolysaccharides produced by Bifidobacterium longum IPLA E44 and Bifidobacterium animalis subsp. lactis IPLA R1 modify the composition and metabolic activity of human faecal microbiota in pH-controlled batch cultures.
    Salazar N; Ruas-Madiedo P; Kolida S; Collins M; Rastall R; Gibson G; de Los Reyes-Gavilán CG
    Int J Food Microbiol; 2009 Nov; 135(3):260-7. PubMed ID: 19735956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dietary prebiotics, probiotic and synbiotics on performance, caecal bacterial populations and caecal fermentation concentrations of broiler chickens.
    Mookiah S; Sieo CC; Ramasamy K; Abdullah N; Ho YW
    J Sci Food Agric; 2014 Jan; 94(2):341-8. PubMed ID: 24037967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro effects of selected synbiotics on the human faecal microbiota composition.
    Saulnier DM; Gibson GR; Kolida S
    FEMS Microbiol Ecol; 2008 Dec; 66(3):516-27. PubMed ID: 18673391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics.
    Krumbeck JA; Rasmussen HE; Hutkins RW; Clarke J; Shawron K; Keshavarzian A; Walter J
    Microbiome; 2018 Jun; 6(1):121. PubMed ID: 29954454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of diverse oligosaccharides for growth by Bifidobacterium and Lactobacillus species and their in vitro co-cultivation characteristics.
    Dong Y; Han M; Fei T; Liu H; Gai Z
    Int Microbiol; 2024 Jun; 27(3):941-952. PubMed ID: 37946011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synbiotic Effect of
    Marsaux B; Van den Abbeele P; Ghyselinck J; Prioult G; Marzorati M; Bogićević B
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32751149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of antimicrobial synbiotics using potentially-probiotic faecal isolates of Lactobacillus fermentum and Bifidobacterium longum.
    Likotrafiti E; Tuohy KM; Gibson GR; Rastall RA
    Anaerobe; 2013 Apr; 20():5-13. PubMed ID: 23354005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the synbiotic properites of human milk oligosaccharides and Bifidobacterium longum subsp. infantis in vitro and in humanised mice.
    Musilova S; Modrackova N; Hermanova P; Hudcovic T; Svejstil R; Rada V; Tejnecky V; Bunesova V
    Benef Microbes; 2017 Apr; 8(2):281-289. PubMed ID: 28116928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galacto-oligosaccharides have prebiotic activity in a dynamic in vitro colon model using a (13)C-labeling technique.
    Maathuis AJ; van den Heuvel EG; Schoterman MH; Venema K
    J Nutr; 2012 Jul; 142(7):1205-12. PubMed ID: 22623395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro screening of probiotic lactic acid bacteria and prebiotic glucooligosaccharides to select effective synbiotics.
    Grimoud J; Durand H; Courtin C; Monsan P; Ouarné F; Theodorou V; Roques C
    Anaerobe; 2010 Oct; 16(5):493-500. PubMed ID: 20670686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro Fermentation of caprine milk oligosaccharides by bifidobacteria isolated from breast-fed infants.
    Thum C; Roy NC; McNabb WC; Otter DE; Cookson AL
    Gut Microbes; 2015; 6(6):352-63. PubMed ID: 26587678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid-state fermentation of whole oats to yield a synbiotic food rich in lactic acid bacteria and prebiotics.
    Zhang N; Li D; Zhang X; Shi Y; Wang H
    Food Funct; 2015 Aug; 6(8):2620-5. PubMed ID: 26130143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro fermentation of prebiotic oligosaccharides by Bifidobacterium lactis HN019 and Lactobacillus spp.
    Sims IM; Ryan JL; Kim SH
    Anaerobe; 2014 Feb; 25():11-7. PubMed ID: 24239979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of synbiotic combinations of commercial probiotic strains with different prebiotics in in vitro and ex vivo human gut microcosm model.
    Raval SD; Archana G
    Arch Microbiol; 2024 Jun; 206(7):315. PubMed ID: 38904672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective Utilization of the Human Milk Oligosaccharides 2'-Fucosyllactose, 3-Fucosyllactose, and Difucosyllactose by Various Probiotic and Pathogenic Bacteria.
    Salli K; Hirvonen J; Siitonen J; Ahonen I; Anglenius H; Maukonen J
    J Agric Food Chem; 2021 Jan; 69(1):170-182. PubMed ID: 33382612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.